A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation - Jorenby, Douglas E; Leischow, Scott J; Nides, Mitchell A; Rennard, Stephen I; Johnston, J. Andrew; Hughes, Arlene R; Smith, Stevens S; Muramoto, Myra L; Daughton, David M; Doan, Kimberli; Fiore, Michael C; Baker, Timothy B (The New England journal of medicine, 1999)
Keywords: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation - adverse effects; Antidepressive Agents, Second-Generation - therapeutic use; Biological and medical sciences; Bupropion - adverse effects; Bupropion - therapeutic use; Delayed-Action Preparations; Drug therapy; Drug Therapy, Combination; Female; Humans; Male; Medical research; Medical sciences; Nicotine - adverse effects; Nicotine - therapeutic use; Smoking cessation; Smoking Cessation - methods; Smoking Cessation - psychology; Smoking Cessation - statistics & numerical data; Substance Withdrawal Syndrome; Tobacco, tobacco smoking; Toxicology; Weight Gain; United States; North America; America; Human; Drug addiction; Amfebutamone; Statistical analysis; Psychotropic; Distributed database; Weaning; Treatment efficiency; Tobacco smoking; Statistics; Long term; Computer science; Placebo; Antidepressant agent; Clinical trial; Patch; Public health; Nicotine